Set1-mediated histone H3K4 methylation is required for azole induction of the ergosterol biosynthesis genes and antifungal drug resistance in Candida glabrata

Kortany M. Baker, Smriti Hoda, Debasmita Saha, Livia Georgescu, Nina D. Serratore, Yueping Zhang, Nadia A. Lanman, Scott BriggsbioRxiv 2021 · DOI

TL;DR

This study reveals that the epigenetic modification H3K4 methylation, mediated by the Set1 enzyme, is crucial for Candida glabrata's ability to induce ergosterol biosynthesis genes in response to azole antifungal drugs. Loss of Set1 leads to increased azole susceptibility, not by affecting drug efflux, but by impairing the induction of these essential genes, highlighting a novel epigenetic vulnerability in this opportunistic pathogen.

What Problem Does This Paper Address?

Candida glabrata is a significant opportunistic fungal pathogen that is notoriously difficult to treat due to its intrinsic resistance to azole antifungal drugs and its ability to develop multidrug resistance. While resistance mechanisms like drug efflux pump overexpression and target gene mutations are well-studied, the role of epigenetic modifications in azole resistance and gene regulation in C. glabrata has remained largely unexplored. This paper aims to bridge this knowledge gap by investigating the contribution of histone H3K4 methylation, a key epigenetic mark, to azole-induced gene expression and drug resistance in C. glabrata.

Methods

The researchers employed a multi-pronged approach to investigate the role of Set1 and H3K4 methylation:

  • Yeast Genetics: They generated and utilized various Candida glabrata and Saccharomyces cerevisiae strains, including deletions of SET1 and its COMPASS complex subunits, as well as strains with mutations in histone H3.
  • Phenotypic Assays: Serial dilution spot assays and liquid growth curves were used to assess azole drug susceptibility and growth phenotypes under drug treatment. Minimal Inhibitory Concentration (MIC) assays were also performed to quantify drug resistance.
  • Molecular Biology Techniques:
    • Western Blotting: Used to detect and quantify different levels of H3K4 methylation (mono-, di-, and trimethylation) in various mutant strains.
  • Quantitative Real-Time PCR (qRT-PCR): Employed to measure the transcript levels of specific genes, including drug efflux pumps (CDR1, PDR1) and ergosterol biosynthesis genes (ERG genes).
  • RNA-Sequencing (RNA-seq): Performed to conduct a genome-wide analysis of gene expression changes in set1Δ strains compared to wild-type under azole treatment.
  • Chromatin Immunoprecipitation (ChIP): Used to determine the enrichment of H3K4 trimethylation on the chromatin of specific ERG genes.
  • Nile Red Assay: A fluorescence-based assay to assess the functional activity of the Cdr1 drug efflux pump.

Datasets

The study utilized existing strains of Saccharomyces cerevisiae (e.g., BY4741) and Candida glabrata (e.g., ATCC 2001, ATCC 200989) obtained from standard collections. New strains were generated through genetic manipulation. RNA-seq data was generated by the authors and analyzed using standard bioinformatics pipelines (Trimmomatic, STAR, HTSeq, DESeq2).

Key Insights and Ideas

  • H3K4 Methylation is a Conserved Regulator of Azole Resistance: The findings demonstrate that Set1-mediated H3K4 methylation plays a similar, critical role in azole drug resistance in both S. cerevisiae and C. glabrata. This suggests a conserved epigenetic mechanism across related fungal species.
  • Resistance is NOT Due to Drug Efflux: A key finding is that the increased azole susceptibility in set1Δ strains is not caused by altered expression or function of major drug efflux pumps like Cdr1 or the transcription factor Pdr1. This shifts the focus away from a common resistance mechanism.
  • Set1 Orchestrates Azole-Induced Gene Expression: The study pinpoints Set1's essential role in inducing the expression of genes involved in the ergosterol biosynthesis pathway, particularly ERG11 (the azole target) and ERG3, when C. glabrata is exposed to azoles.
  • Epigenetic Mark on Target Genes: ChIP analysis directly shows that H3K4 trimethylation is enriched on the chromatin of ERG genes, and this enrichment increases upon azole treatment, directly linking the epigenetic mark to gene activation.
  • Catalytic Activity is Essential: The study confirms that the catalytic activity of Set1's SET domain is crucial for H3K4 methylation and subsequent azole resistance, as a catalytically inactive mutant failed to rescue the set1Δ phenotype.

Key Results

  • Deletion of SET1 in C. glabrata and S. cerevisiae leads to increased susceptibility to azole drugs like fluconazole.
  • Loss of Set1 abolishes all forms of H3K4 methylation (mono-, di-, and trimethylation) in C. glabrata.
  • Genome-wide RNA-seq analysis revealed that Set1 is required for the azole-induced expression of 12 genes in the late ergosterol biosynthesis pathway, including ERG11 and ERG3.
  • ChIP analysis demonstrated that H3K4 trimethylation is enriched on the chromatin of ERG11 and ERG3 and increases upon azole treatment.
  • A catalytically inactive mutant of Set1 (H1048K) failed to restore H3K4 methylation or azole resistance in set1Δ strains.
  • Transcript levels of CDR1 and PDR1 were not significantly altered in set1Δ strains, and the Cdr1 efflux pump function remained intact.

Limitations and Future Work

  • Mechanistic Details of COMPASS Subunits: While the study investigated several COMPASS complex subunits, the precise differential roles and assembly mechanisms of these subunits in C. glabrata (e.g., the distinct behavior of CgSpp1 compared to other subunits) warrant further investigation.
  • Regulation of CDR1 and PDR1: Although not directly implicated in the set1Δ phenotype, the paper suggests that further investigation is needed to understand how CDR1 and PDR1 are epigenetically regulated in C. glabrata.
  • Role in Virulence: The study primarily focuses on drug resistance. While it briefly speculates on the impact of Set1 loss on virulence in C. albicans and C. glabrata, a more direct investigation into the Set1-ERG pathway's role in fungal pathogenesis is a promising future direction.
  • Broader Epigenetic Landscape: The paper highlights H3K4 methylation but acknowledges that other epigenetic factors (like histone deacetylases) are also involved in azole resistance, suggesting a complex interplay that could be explored further.
  • Cross-Species Comparisons: While comparisons are made between S. cerevisiae and C. glabrata, understanding the precise reasons for differences in azole sensitivity and gene regulation (e.g., sterol uptake mechanisms) across different Candida species remains an area for future research.

Summary updated

Abstract

ABSTRACT Candida glabrata is an opportunistic pathogen that has developed the ability to adapt and thrive under azole treated conditions. The common mechanisms that can result in Candida drug resistance are due to mutations or overexpression of the drug efflux pump or the target of azole drugs, Cdr1 and Erg11, respectively. However, the role of epigenetic histone modifications in azole-induced gene expression and drug resistance are poorly understood in C. glabrata . In this study, we show for the first time that Set1 mediates histone H3K4 mono-, di-, and trimethylation in C. glabrata . In addition, loss of SET1 and histone H3K4 methylation results in increased susceptibility to azole drugs in both C. glabrata and S. cerevisiae . Intriguingly, this increase in susceptibility to azole drugs in strains lacking Set1-mediated histone H3K4 methylation is not due to altered transcript levels of CDR1 , PDR1 or Cdr1’s ability to efflux drugs. Genome-wide transcript analysis revealed that Set1 is necessary for azole-induced expression of 12 genes involved in the late biosynthesis of ergosterol including ERG11 and ERG3 . Importantly, chromatin immunoprecipitation analysis showed that histone H3K4 trimethylation was detected on chromatin of actively transcribed ERG genes. Furthermore, H3K4 trimethylation increased upon azole-induced gene expression which was also found to be dependent on the catalytic activity of Set1. Altogether, our findings show that Set1-mediated histone H3K4 methylation governs the intrinsic drug resistant status in C. glabrata via epigenetic control of azole-induced ERG gene expression. IMPORTANCE C. glabrata is the second most commonly isolated species from Candida infections, coming in second to C. albicans . Treatment of C. glabrata infections are difficult due to their natural resistance to antifungal azole drugs and their ability to adapt and become multidrug resistant. In this study, we investigated the contributing cellular factors for controlling drug resistance. We have determined that an epigenetic mechanism governs the expression of genes involved in the late ergosterol biosynthesis pathway, an essential pathway that antifungal drugs target. This epigenetic mechanism involves histone H3K4 methylation catalyzed by the Set1 methyltransferase complex (COMPASS). We also show that Set1-mediated histone H3K4 methylation is needed for expression of specific azole induced genes and azole drug resistance in C. glabrata . Identifying epigenetic mechanisms contributing to drug resistance and pathogenesis could provide alternative targets for treating patients with fungal infections.
BibTeX
@misc{baker2021set,
  author = {Kortany M. Baker and Smriti Hoda and Debasmita Saha and Livia Georgescu and Nina D. Serratore and Yueping Zhang and Nadia A. Lanman and Scott Briggs},
  title = {{Set1-mediated histone H3K4 methylation is required for azole induction of the ergosterol biosynthesis genes and antifungal drug resistance in <i>Candida glabrata</i>}},
  year = {2021},
  doi = {10.1101/2021.11.17.469015},
  howpublished = {bioRxiv},
}
Figure